Biologics—drugs made from living organisms—are used to treat everything from arthritis to cancer, and Americans spent $40 billion on them last year. Now, nearly 20 years after patent protection is about to expire ... more
Three drugs -- Vioxx, Ketek and Avandia -- are casting long shadows over the congressional debate on how to update and revise the 15-year-old system that has dramatically sped up the process of bringing prescription medicines to American consumers... more
Follow-On Biologics Bill - WASHINGTON (Reuters) -- A Senate panel voted Wednesday to set a path for generic drugmakers to seek approval of cheaper, copycat versions of expensive biotechnology medicines. more
Conflict in Drug Company - Physician Relationships - Drug companies have become the biggest sponsors of continuing medical education courses in recent years, even at the nation's top medical schools, a development that critics say raises health-care costs, skews doctors' treatment decisions and allows ... more
